Ameren Announces Second Quarter 2025 Results

— Second Quarter Diluted Earnings Per Share were $1.01 in 2025 vs. $0.97 in 2024 — Reaffirm 2025 Diluted EPS Guidance Range of $4.85 to $5.05 Per Share Ameren Corporation (NYSE: AEE) today announced second quarter 2025 net income attributable to common shareholders of $275 million, or $1.01 per diluted share, compared to second quarter […]

Gray Media Agrees to Purchase Two Television Stations from SagamoreHill Broadcasting

(NYSE:GTN),(NYSE:GTN-A), ATLANTA, July 31, 2025 (GLOBE NEWSWIRE) — Gray Media has reached an agreement to acquire SagamoreHill Broadcasting's WLTZ, the NBC affiliate for the Columbus, Georgia, market (DMA 127), and KJTV, the FOX affiliate for the Lubbock, Texas, market (DMA 140). For the past several years, Gray has provided back-office services to both stations through

FibroBiologics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

(NASDAQ:FBLG), HOUSTON, July 31, 2025 (GLOBE NEWSWIRE) — FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced second quarter 2025 financial results and provided a corporate update. Recent

RCM Technologies, Inc. Announces Conference Call

(NasdaqGM:RCMT), PENNSAUKEN, N.J., July 31, 2025 (GLOBE NEWSWIRE) — RCM Technologies, Inc. (NasdaqGM: RCMT) will hold a conference call on Thursday, August 7, 2025 at 11:30 a.m. Eastern time to discuss the financial results for the thirteen and twenty-six weeks ended June 28, 2025. The teleconference dial-in numbers are (888) 272-8703 for domestic callers and

Host Hotels & Resorts Provides Updated Second Quarter 2025 Investor Presentation

(NASDAQ:HST), BETHESDA, Md., July 31, 2025 (GLOBE NEWSWIRE) — Host Hotels & Resorts, Inc. (NASDAQ: HST) (the “Company”), the nation's largest lodging real estate investment trust, today provided an updated investor presentation for second quarter 2025 results. The investor presentation can be found on the Investor Relations section on the Company's website at https://www.hosthotels.com/#key-investors-materials. ABOUT

QUAINT OAK BANCORP, INC. ANNOUNCES SECOND QUARTER EARNINGS

(Other OTC:QNTO),(OTC US:QNTO), Southampton, PA , July 31, 2025 (GLOBE NEWSWIRE) — Quaint Oak Bancorp, Inc. (the “Company”) (OTCQB: QNTO), the holding company for Quaint Oak Bank (the “Bank”), announced today net income for the quarter ended June 30, 2025 of $272,000, or $0.10 per basic and diluted share, compared to net income of $100,000,

RGC Resources, Inc. Schedules Third Quarter 2025 Earnings Call

(NasdaqGM:RGCO), ROANOKE, Va., July 31, 2025 (GLOBE NEWSWIRE) — RGC Resources, Inc. (Nasdaq: RGCO) will host its quarterly conference call and webcast to review the results of its fiscal third quarter 2025 on Wednesday, August 13, 2025 at 9:00 a.m. eastern time. Related presentation materials will be available before the call on the Company website

Aspen Aerogels to Participate in August Investor Conferences

(NYSE:ASPN), NORTHBOROUGH, Mass., July 31, 2025 (GLOBE NEWSWIRE) — Aspen Aerogels, Inc. (NYSE: ASPN) (“Aspen” or the “Company”), a technology leader in sustainability and electrification solutions, today announced that the Company is scheduled to participate in the following investor events in August: (i) Oppenheimer 28th Annual Technology, Internet & Communications Conference, and (ii) Canaccord Genuity

Knight Therapeutics Announces Regulatory Supplemental Submission of MINJUVI(R) (tafasitamab) for Follicular Lymphoma in Brazil

(TSX:GUD),(NASDAQ:INCY), MONTREAL, July 31, 2025 (GLOBE NEWSWIRE) — Knight Therapeutics Inc., (TSX: GUD) (“Knight”) a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Brazilian affiliate, United Medical Ltda., has submitted a supplemental application to ANVISA, the Brazilian health regulatory agency, seeking approval for an additional indication for MINJUVI(R) (tafasitamab) in combination with rituximab and

Precipio Announces Q2-2025 Shareholder Update Call

(NASDAQ:PRPO), NEW HAVEN, Conn., July 31, 2025 (GLOBE NEWSWIRE) — Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q2-2025 corporate update call on August 14th, 2025 at 5:00 PM ET. The call will include updates on all of the company's current core businesses. The conference call may be accessed by calling

Scroll to Top